Skip to main content

Table 3 Hospital costs (US Dollars)*

From: Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study

 

AMB Period vs. AZ Period

AZ Period

 

AMB Period (n = 259)

AZ Period (n = 321)

p-value1

FLU (n = 237)

VOR (n = 84)

Mean Total

$44,129

$53,257

0.0141

$42,350

$66,975

Costs2

($39,643–$49,122)

($47,834–$59,296)

 

($37,952–$47,257)

($55,892–$80,255)

Mean Pharm

$10,361

$19,751

<0.0001

$12,009

$32,484

Costs2

($9,043–$11,871)

($17,229–$22,642)

 

($10,447–$13,805)

($25,792–$40,911)

Mean Lab

$438

$506

0.02

$467

$548

Costs2

($402–$477)

($464–$552)

 

($427–$510)

($473–$636)

  1. 1p-values are from mixed effects logistic regression models that controlled for the number of hospitalizations. P-values reflect the comparison of the cost in the AZ period relative to the cost in the AMB period
  2. 2Reported means are least squared means from mixed effects regression models that controlled for the number of hospitalizations
  3. All costs are rounded to the nearest dollar. All costs are means (lower 95% confidence interval to upper 95% confidence interval)
  4. Note: AMB = Amphotericn; AZ = Azole; FLU = flunconazole; VOR = voriconazole; Pharm = pharmacy; Lab = Laboratory.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us